RxDoctor Payments Data

Kent Johnson

Anatomic Pathology · Ann Arbor, MINPI 1174605117

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $228,900 of the $228,900 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Pfizer. Reporting peaked in 2019 at $45,500 and has fallen 93.8% since, to $2,800 in 2025. Among anatomic pathology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$228,900in general payments, 2019–2025

Across 69 payments — averaging $3317.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$229K
$537,312in research payments, 2019–2025

Across 10 payments — averaging $53,731 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$478K
  • Takeda Pharmaceuticals U.S.A., Inc.$60K

What the payments were for

  • Consulting fees$228,900100%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer69$228,900

How this compares

$228,900 in reported general payments places this provider in the 95th percentile of 36 anatomic pathology providers in Michigan.

See all anatomic pathology providers in Michigan →

Other anatomic pathology in Ann Arbor

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →